MEI Pharma (MEIP) Short Interest Ratio & Short Volume → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free MEIP Stock Alerts $3.15 +0.22 (+7.51%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability MEI Pharma Short Interest DataCurrent Short Volume22,800 sharesPrevious Short Volume20,900 sharesChange Vs. Previous Month+9.09%Dollar Volume Sold Short$69,540.00Short Interest Ratio / Days to Cover1.1Last Record DateApril 30, 2024Outstanding Shares6,660,000 sharesFloat Size6,150,000 sharesShort Percent of Float0.37%Today's Trading Volume13,284 sharesAverage Trading Volume21,504 sharesToday's Volume Vs. Average62% Short Selling MEI Pharma ? Sign up to receive the latest short interest report for MEI Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEIP Short Interest Over TimeMEIP Days to Cover Over TimeMEIP Percentage of Float Shorted Over Time Ad Stansberry ResearchA letter is coming from the "Bureau of the Fiscal Service".Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.See if your bank is involved right here. MEI Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202422,800 shares $69,540.00 +9.1%0.4%1.1 $3.05 4/15/202420,900 shares $67,925.00 +168.0%0.3%1 $3.25 3/31/20247,800 shares $31,200.00 -14.3%0.1%0.3 $4.00 3/15/20249,100 shares $34,853.00 -27.2%0.2%0.4 $3.83 2/29/202412,500 shares $51,875.00 +23.8%0.2%0.4 $4.15 2/15/202410,100 shares $46,157.00 -97.0%0.2%0.3 $4.57 Get the Latest News and Ratings for MEIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024331,500 shares $1.49 million -1.1%5.4%7 $4.50 1/15/2024335,200 shares $1.94 million -0.7%5.5%6.7 $5.80 12/31/2023337,500 shares $1.96 million -7.5%5.5%6.9 $5.80 12/15/2023365,000 shares $2.31 million -5.7%5.9%7.1 $6.33 11/30/2023386,900 shares $2.38 million -2.8%6.3%6.6 $6.14 11/15/2023398,100 shares $3.12 million -25.7%6.5%7.4 $7.84 10/31/2023536,100 shares $3.66 million +7.4%8.9%13 $6.82 10/15/2023499,000 shares $3.34 million +18.8%8.2%12.4 $6.70 9/30/2023419,900 shares $2.94 million +57.3%6.9%9.1 $7.01 9/15/2023267,000 shares $1.38 million +3.6%4.4%6.1 $5.18 8/31/2023257,700 shares $1.37 million -29.8%4.3%7 $5.32 8/15/2023367,300 shares $2.57 million +16.0%6.1%7.9 $7.00 7/31/2023316,700 shares $2.24 million +1.1%5.2%5.7 $7.07 7/15/2023313,200 shares $2.33 million -4.7%5.2%4.8 $7.44 6/30/2023328,700 shares $2.16 million +2.3%5.4%5.1 $6.58 6/15/2023321,300 shares $2.37 million +5.6%5.3%4.8 $7.38 5/31/2023304,400 shares $2.34 million +28.4%5.0%4.2 $7.70 5/15/2023237,100 shares $1.69 million -14.7%3.9%2.9 $7.11 4/30/2023277,900 shares $1.41 million +17.7%4.6%3.8 $5.09 4/15/2023236,100 shares $1.13 million -95.6%3.9%3.9 $4.80 3/31/20235,340,000 shares $1.22 million +1.3%N/A5 $0.23 3/15/20235,270,000 shares $1.32 million +20.9%N/A4.7 $0.25 2/28/20234,360,000 shares $968,792.00 +0.9%N/A3 $0.22 2/15/20234,320,000 shares $1.31 million +24.1%N/A3.2 $0.30 1/31/20233,480,000 shares $992,496.00 -23.7%N/A2.8 $0.29 1/15/20234,560,000 shares $1.49 million +19.4%N/A3.6 $0.33 12/30/20223,820,000 shares $930,552.00 +11.7%N/A3 $0.24 12/15/20223,420,000 shares $837,900.00 -25.3%N/A2.7 $0.25 11/30/20224,580,000 shares $1.56 million +4.8%N/A3.9 $0.34 11/15/20224,370,000 shares $1.51 million -13.3%N/A5.9 $0.34 10/31/20225,040,000 shares $1.71 million +2.7%N/A6.8 $0.34 10/15/20224,910,000 shares $1.85 million +4.9%N/A6.1 $0.38 9/30/20224,680,000 shares $1.81 million +0.7%N/A5.1 $0.39 9/15/20224,650,000 shares $2.32 million -0.6%N/A2.9 $0.50[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. MEIP Short Interest - Frequently Asked Questions What is MEI Pharma's current short interest? Short interest is the volume of MEI Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 22,800 shares of MEIP short. 0.37% of MEI Pharma's shares are currently sold short. Learn More on MEI Pharma's current short interest. What is a good short interest ratio for MEI Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEIP shares currently have a short interest ratio of 1.0. Learn More on MEI Pharma's short interest ratio. What is a good short interest percentage for MEI Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of MEI Pharma's floating shares are currently sold short. Is MEI Pharma's short interest increasing or decreasing? MEI Pharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 22,800 shares, an increase of 9.1% from the previous total of 20,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MEI Pharma's float size? MEI Pharma currently has issued a total of 6,660,000 shares. Some of MEI Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MEI Pharma currently has a public float of 6,150,000 shares. How does MEI Pharma's short interest compare to its competitors? 0.37% of MEI Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MEI Pharma: Orgenesis Inc. (0.84%), Lumos Pharma, Inc. (6.09%), Alaunos Therapeutics, Inc. (9.57%), Synlogic, Inc. (0.36%), Benitec Biopharma Inc. (6.27%), BioVie Inc. (3.18%), Cumberland Pharmaceuticals Inc. (0.23%), NeuroBo Pharmaceuticals, Inc. (2.06%), KALA BIO, Inc. (0.36%), CytoMed Therapeutics Limited (1.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short MEI Pharma stock? Short selling MEIP is an investing strategy that aims to generate trading profit from MEI Pharma as its price is falling. MEIP shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MEI Pharma? A short squeeze for MEI Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEIP, which in turn drives the price of the stock up even further. How often is MEI Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEIP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ORGS Short Squeeze LUMO Short Squeeze TCRT Short Squeeze SYBX Short Squeeze BNTC Short Squeeze BIVI Short Squeeze CPIX Short Squeeze NRBO Short Squeeze KALA Short Squeeze GDTC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEIP) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace